Skip to main content

Table 1 Patient characteristics

From: Long-term results and PSA kinetics after robotic SBRT for prostate cancer: multicenter retrospective study in Korea (Korean radiation oncology group study 15–01)

 

n

%

age, years

 median

69.5

 

 range

47–81

 

initial PSA, ng/ml

 median

6.95

 

 range

2.05–23.04

 

preCK PSA, ng/ml

 median

6.65

 

 range

0.01–21.62

 

T stage

 1c

27

30.7

 2a

19

21.6

 2b

14

15.9

 2c

27

30.7

 3a

1

1.1

Gleason score

  ≤ 6

56

63.7

 7

20

22.7

  ≥ 8

12

13.6

Risk group

 low

24

27.3

 intermediate

50

56.5

 high

14

15.9

ADT

 no

74

84.1

 yes

14

15.9

Prostate volume, ml

 median

40.0

 

 range

12.0–94.8

 

Initial IPSS

 Median

3

 

 range

0–15

 
  1. Abbreviations: PSA Prostate-specific antigen, ADT Androgen deprivation therapy, IPSS International prostate symptom score
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us